Core Insights - Solésence, Inc. will report its second quarter 2025 results on July 31, 2025, after market close [1] - The company will host a conference call and webcast on the same date to discuss the results [1] Conference Call Details - The conference call is scheduled for July 31, 2025, at 4:00 p.m. CDT, 5:00 p.m. EDT [2] - Speakers will include Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer [2] - Registration is required to receive the dial-in number and personalized PIN for the call [2][3] Company Overview - Solésence, Inc. is a leader in scientifically-driven health care solutions in beauty and life science categories [4] - The company focuses on innovation, inclusivity, and the science of beautiful skin, particularly in mineral-based sun protection [4] - Solésence integrates protection, prevention, and treatment technologies into daily use products, enhancing skin health solutions [4]

Core Insights - Solésence, Inc. has amended its loan agreements to increase borrowing capacity and extend maturity dates, enhancing financial flexibility for strategic objectives [1][2][3] Financial Details - The maximum borrowing capacity has increased from $14.2 million to $23.0 million, with maturity dates extended from October 1, 2025, to April 30, 2027 [2] Strategic Objectives - The additional borrowing capacity will support procurement of key raw materials, improve lead times for packaging and product launches, and empower brand partners to drive product adoption [3] Leadership Commentary - The President and CEO of Solésence emphasized that the increased financial capacity and extended timeline will be crucial for scaling operations and serving brand partners effectively [4]

Core Insights - Solésence, Inc. reported record revenue of $14.6 million for Q1 2025, a 48% increase from $9.9 million in Q1 2024, driven by strong sales and large customer orders [7][2] - The company experienced a significant increase in shipment volume by 95% year-over-year and production volume by 120% year-over-year, indicating robust operational growth [7][2] - Solésence has successfully uplisted to Nasdaq under the ticker "SLSN," enhancing its visibility in the investment community [6][2] Financial Performance - Revenue for Q1 2025 was $14.6 million, up from $9.9 million in Q1 2024, marking a 48% increase [7] - Gross profit decreased to $3.3 million in Q1 2025 from $3.6 million in Q1 2024, resulting in a gross margin of 23%, down from 36% in the previous year [7] - Net income for Q1 2025 was breakeven, compared to a net income of $0.9 million in Q1 2024 [7] Operational Highlights - The company launched a multi-SKU product line for a new strategic brand partner, which incurred one-time start-up costs affecting gross margins [2] - Solésence anticipates continued sequential revenue growth with current shipped and open orders exceeding $45 million [2] - The company has expanded its intellectual property portfolio with new technology allowances in Japan, South Korea, and Mexico [7] Future Outlook - Management expects substantial improvement in gross margin levels as operations scale and fixed manufacturing costs are managed more efficiently [2] - The company aims to capitalize on significant opportunities to drive long-term shareholder value following its Nasdaq uplisting and rebranding efforts [2]

Core Viewpoint - Solésence, Inc. will report its first quarter 2025 results on May 5, 2025, and will host a conference call and webcast on the same day [1]. Group 1: Conference Call Details - The conference call is scheduled for May 5, 2025, at 4:00 p.m. CDT (5:00 p.m. EDT) [2]. - Speakers for the call will include Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer [2]. - Participants must register to receive the dial-in number and personalized PIN [2]. Group 2: Company Overview - Solésence, Inc. is a leader in scientifically-driven health care solutions in beauty and life science categories [4]. - The company's mission focuses on delivering joy through innovation, inclusivity, and the science of beautiful skin [4]. - Solésence has redefined mineral-based sun protection by enhancing transparency, effectiveness, aesthetics, and wearability [4].